Liquid Biopsy Market to Witness a High Growth in Coming Five Years

2026-07-06 08:04:13 Health and Fitness

547

According to a new research report by RNCOS entitled, ?Global Liquid Biopsy Market Outlook to 2020?, the increasing incidence of cancer worldwide has created a demand of developing new and innovated screening technologies.

Emerging versions of the liquid biopsy approach allow physicians to rapidly identify circulating cancerous DNA, enable gene profiling, and develop personalized approaches to treatment. Also, the liquid biopsy is much less invasive and does not require surgery. With more accurate profiling, patients and insurers might stay away from the expense of ineffective drugs.

Most of the current research is focused on utilizing liquid biopsy for diagnostic purposes such as response evaluation, expression profiling, tumor diagnosis and treatment monitoring in a blood test.

Numerous liquid biopsy players such as Biocept, NeoGenomics, Biocartis, Pathway Genomics, are offering liquid biopsy based services using their proprietary technologies. Since research in this field has been garnering a lot of interest due to the wide applicability of liquid biopsy, the market is expected to continue to grow at the double digit rate of 18.1% for the next five years.

Research Analysis and Highlights

The report provides an in-depth analysis of the current status and future prospect of the Global Liquid Biopsy Market Outlook 2020. The study segments and provides market based on the sample type, technology and geography. The report also provides a comprehensive insight about the market dynamics including the drivers, challenges, opportunities, and upcoming trends that would influence the market.

The report also covers detailed information about key players in the global liquid biopsy market, to enable the clients to understand the market structure and its growth during the forecasted period.

Some of the key highlights of the report include the following:

? Growth drivers such as increasing prevalence of Cancer; increasing demand for minimally-invasive biopsy techniques.
? Holistic view of the liquid biopsy market, segmentation in terms of the sample type, the technology, pipeline analysis and the regional prevalence.
? Leading players and their product portfolio in the liquid biopsy market.

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM815.htm

Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm

ABOUT RNCOS

RNCOS is a leading industry research and consultancy firm incorporated in 2002. As a pioneer in syndicate market research, our vision is to be a global leader in the industry research space by providing research reports and actionable insights to companies across a range of industries such as Healthcare, IT and Telecom and Retail etc. We offer comprehensive industry research studies, bespoke research and consultancy services to Fortune 1000, Trade associations, and Government agencies worldwide.